Role of insulin‐like growth factor binding protein‐3 in breast cancer cell growth
- 19 September 2002
- journal article
- review article
- Published by Wiley in Microscopy Research and Technique
- Vol. 59 (1) , 12-22
- https://doi.org/10.1002/jemt.10173
Abstract
The mitogenic effects of insulin‐like growth factors (IGFs) are regulated by a family of insulin‐like growth factor binding proteins (IGFBPs). One member of this family, IGFBP‐3, mediates the growth‐inhibitory and apoptosis‐inducing effects of a number of growth factors and hormones such as transforming growth factor‐β, retinoic acid, and 1,25‐dihydroxyvitamin D3. IGFBP‐3 may act in an IGF‐dependent manner by attenuating the interaction of pericellular IGFs with the type‐I IGF receptor. It may also act in an IGF‐independent manner by initiating intracellular signaling from a cell surface receptor, or by direct nuclear action, or both. The possibility of a membrane‐bound receptor is strengthened by recent studies which have identified members of the transforming growth factor‐β receptor family as having a role, either directly or indirectly, in signaling from the cell surface by IGFBP‐3. A number of growth factors and hormones stimulate the expression and secretion of cellular IGFBP‐3, which then signals from the cell surface to bring about some of the effects attributed to the primary agents. Within the cell, the apoptosis‐inducing tumor suppressor, p53, can also induce IGFBP‐3 expression and secretion. Since IGFBP‐3 upregulates the cell cycle inhibitor, p21Waf1, and increases the ratio of proapoptotic to antiapoptotic members of the Bcl family, it appears to exert the same effects on major downstream targets of cell signaling as p53 does. The nuclear localization of IGFBP‐3 has been described in a number of cell types. IGFBP‐3 may act to import IGFs or other nuclear localization signal‐deficient signaling molecules into the nucleus. It may also act directly in the nucleus by enhancing the activity of retinoid X receptor‐α and thereby promote apoptosis. All of the above phenomena will be discussed with particular emphasis on the growth of breast cancer cells. Microsc. Res. Tech. 59:12–22, 2002.Keywords
This publication has 115 references indexed in Scilit:
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000
- Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and ApoptosisJournal of Biological Chemistry, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer CellsBiochemical and Biophysical Research Communications, 1997
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsJournal of Biological Chemistry, 1996
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Transforming Growth Factor β1 Induces Apoptotic Cell Death in Cultured Human Umbilical Vein Endothelial Cells with Down-Regulated Expression of BCL-2Biochemical and Biophysical Research Communications, 1995
- Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell lineJournal of Cellular Physiology, 1994
- Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signallingNature, 1992
- Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor β in normal and transformed cellsBiochemical and Biophysical Research Communications, 1991